Trial
NCT01856257
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Clinical Trials in Organ Transplantation
Condition
Primary Renal Allograft Candidate
Intervention
Anti-thymocyte Globulin (Rabbit)
Why stopped
Safety: Stopping rule not met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-17